Editorial
Authors
1 Department of Clinical Pharmacy, UCSI University, Kuala Lumpur, Malaysia
2 Department of Biopharmaceutical Sciences, Shenandoah University, Winchester, USA
1. Ahmad A, Patel I, Sanyal S, Balkrishnan R, Mohanta GP.
Availability, cost and affordability of antimalarial medicines
in India. Int J Pharm Clin Res 2014;6:7-12.
2. National Pharmaceutical Pricing Authority, Department
of Pharmaceuticals, Ministry of Chemical and Fertilizers,
Government of India. Available from: http://www.nppaindia.
nic.in/index1.html. [Last accessed on 2014 Oct 05].
3. Selvaraj S. How Effective Is India’s Drug Price Control Regime?
Boston, MA, USA: Harvard School of Public Health; 2007.
Available from: https://www.hsph.harvard.edu/wp-content/uploads/sites/114/2012/10/RP256.pdf. [Last accessed on
2014 Oct 06].
4. Iftikhar G. New Delhi, Cancer Drug Price Goes Up from
Rs. 8,000 to Rs. 1.08 lakh. Available from: http://www.
dnaindia.com/india/report-cancer-drug-price-goes-up-fromrs-8000-to-rs-108-lakh-2022667. [Last accessed on 2014 Oct 06].
5. Maken A. How Indian Cancer/TB/AIDS and Heart Patients to
Bear the Cost of Modi’s American Jamboree. Available from:
http://www.ajaymakenblog.wordpress.com/. [Last accessed
on 2014 Oct 05].
6. Srinath Reddy K, Shah B, Varghese C, Ramadoss A.
Responding to the threat of chronic diseases in India. Lancet
2005;366:1744-9.
7. Sharma K. Burden of non-communicable diseases in India:
Setting priority for action. Int J Med Sci Public Health
2013;2:6-11.
8. Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A,
et al. Prices and availability of common medicines at six sites
in India using a standard methodology. Indian J Med Res
2007;125:645-54.
Availability, cost and affordability of antimalarial medicines
in India. Int J Pharm Clin Res 2014;6:7-12.
2. National Pharmaceutical Pricing Authority, Department
of Pharmaceuticals, Ministry of Chemical and Fertilizers,
Government of India. Available from: http://www.nppaindia.
nic.in/index1.html. [Last accessed on 2014 Oct 05].
3. Selvaraj S. How Effective Is India’s Drug Price Control Regime?
Boston, MA, USA: Harvard School of Public Health; 2007.
Available from: https://www.hsph.harvard.edu/wp-content/uploads/sites/114/2012/10/RP256.pdf. [Last accessed on
2014 Oct 06].
4. Iftikhar G. New Delhi, Cancer Drug Price Goes Up from
Rs. 8,000 to Rs. 1.08 lakh. Available from: http://www.
dnaindia.com/india/report-cancer-drug-price-goes-up-fromrs-8000-to-rs-108-lakh-2022667. [Last accessed on 2014 Oct 06].
5. Maken A. How Indian Cancer/TB/AIDS and Heart Patients to
Bear the Cost of Modi’s American Jamboree. Available from:
http://www.ajaymakenblog.wordpress.com/. [Last accessed
on 2014 Oct 05].
6. Srinath Reddy K, Shah B, Varghese C, Ramadoss A.
Responding to the threat of chronic diseases in India. Lancet
2005;366:1744-9.
7. Sharma K. Burden of non-communicable diseases in India:
Setting priority for action. Int J Med Sci Public Health
2013;2:6-11.
8. Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A,
et al. Prices and availability of common medicines at six sites
in India using a standard methodology. Indian J Med Res
2007;125:645-54.
)